NASDAQ:QMCO

Quantum Corporation's Upcoming Earnings Report: A Financial Overview

Font: Financial Modeling Prep  • Feb 10, 2026

Market Chart
  • Quantum Corporation (NASDAQ:QMCO) is set to release its quarterly earnings with an anticipated EPS of -$0.42 and revenue of $72.7 million.
  • The company's financial metrics indicate challenges, including a negative earnings yield and potential liquidity issues.
  • Key financial ratios such as the P/E ratio, price-to-sales ratio, and debt-to-equity ratio highlight the company's current financial difficulties.

Quantum Corporation, trading on NASDAQ under the symbol QMCO, is preparing to release its quarterly earnings on February 11, 2026. The company is known for its data storage and management solutions. Wall Street anticipates an earnings per share (EPS) of -$0.42 and revenue of $72.7 million. This release will provide insights into the company's financial health and future prospects.

The company's financial metrics reveal some challenges. With a price-to-earnings (P/E) ratio of -0.46, Quantum is currently experiencing negative earnings. This means the company is not generating profit relative to its share price. The price-to-sales ratio of 0.14 indicates that the market values the company's sales at a low level compared to its stock price.

Quantum's enterprise value to sales ratio is 0.50, reflecting its total valuation relative to sales. This suggests that the market may have a cautious outlook on the company's future revenue potential. The enterprise value to operating cash flow ratio of -3.36 highlights difficulties in generating positive cash flow from operations, a critical aspect for sustaining business activities.

The earnings yield of -2.16% further emphasizes Quantum's financial difficulties. This metric shows the return on investment for shareholders is currently negative. Additionally, the debt-to-equity ratio of -0.67 indicates that the company has more liabilities than equity, which can be a concern for investors regarding financial stability.

Lastly, the current ratio of 0.37 suggests potential liquidity issues. This ratio measures the company's ability to cover short-term liabilities with its current assets. A ratio below 1 indicates that Quantum may struggle to meet its short-term obligations, which could impact its operational capabilities.

Market Overview
VRAX
Virax Biolabs Group Limited
$0.24
53.09%
WGRX
Wellgistics Health, Inc.
$0.17
108.38%
AIM
AIM ImmunoTech Inc.
$0.41
61.26%
SBFM
Sunshine Biopharma, Inc.
$0.51
79.51%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$9.95
7.80%
TZA
Direxion Daily Small Cap Bear 3X ETF
$5.05
1.81%
PMI
Picard Medical, Inc.
$0.17
7.06%
GOVX
GeoVax Labs, Inc.
$2.21
79.67%
NXXT
NextNRG Inc.
$0.41
46.22%
CREG
Smart Powerr Corp.
$0.62
30.59%